This book is a common yet incompletely understood problem by general pediatricians. An exhaustive list of causes and multiple classifications add to the complexities of the issues. A Plethora of new antiepileptic drugs has come in market and often we face difficulty in choosing appropriate molecule. Silver lining is that most of pediatric epilepsies are amenable to treatment with an excellent long term outcome provided the workup and management plan is executed methodically.